Significant progresses in IND, clinical development, NDA/BLA, commercialization, BD and financing NDA/BLA progress - GB226 (Geptanolimab) Priority Review for PTCL, GB242 (infliximab (Remicade) ... ( read original story ...)
Shanghai International Airport is about to announce its earnings — here’s what Wall Street expects
Shanghai International Airport will report earnings from Q4. Wall Street predict expect Shanghai International Airport will release losses per share of CNY 0.293. Go ... ( read original story ...)
New Hotel Brands Arrive at Hotel Plus Mockup Room Show This Spring in Shanghai
Hotel Plus Mockup Room Show Press Conference, the pre-event road show organized by Sinoexpo Informa Markets, was successfully held on March 9, 2021 at ... ( read original story ...)
Shanghai Petrochemical Announces 2020 Annual Results Operation Further Optimized and Company Competitiveness Leapfrogged
HONG KONG / ACCESSWIRE / / Sinopec Shanghai Petrochemical Company Limited ("Shanghai Petrochemical" or the "Company", together with ... ( read original story ...)
Why selling KE to Shanghai Electric makes sense
Its name was changed from KESC to just KE or K-Electric and this rebranding also came with a renewed emphasis on improving relations with customers. Of course, that didn’t mean that breakdowns and ... ( read original story ...)
Dalian Wanda to restructure assets after withdrawing troubled Shanghai IPO plan for property arm
Dalian Wanda, controlled by billionaire Wang Jianlin, is seeking to reorganise part of its assets after deciding to withdraw an application to list the group’s real-estate management unit in Shanghai. ( read original story ...)
Shanghai Cell Therapy nets nearly $77m in Series D1 round
The Series D1 round was led by China's Jiuzhou Venture, CCB International, and Shanghai-based Sun Rock Capital. ( read original story ...)